Yongmei X. Yin

300 Guangzhou Road
Nanjing, 210029, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 270 publications

TroFuse-011 study design: sacituzumab tirumotecan with or without pembrolizumab for advanced triple-negative breast cancer with PD-L1 CPS <10.

TroFuse-011 study design: sacituzumab tirumotecan with or without pembrolizumab for advanced triple-negative breast cancer with PD-L1 CPS <10.

Journal: Future oncology (London, England)

Published: July 31, 2026

Mechanotransduction via YAP/TAZ shapes the tumour immune microenvironment.

Mechanotransduction via YAP/TAZ shapes the tumour immune microenvironment.

Journal: Critical reviews in oncology/hematology

Published: June 21, 2026

Dual Innovations Driving Pseudomonas aeruginosa Lipopolysaccharide Core Pentasaccharide Synthesis: Linker Configuration Control and One-Pot Bis-glycosylation.

Dual Innovations Driving Pseudomonas aeruginosa Lipopolysaccharide Core Pentasaccharide Synthesis: Linker Configuration Control and One-Pot Bis-glycosylation.

Journal: Organic letters

Published: June 02, 2026

A glucose metabolism-targeted nanoplatform amplifies disulfidptosis-associated immunogenic cell death in triple-negative breast cancer.

A glucose metabolism-targeted nanoplatform amplifies disulfidptosis-associated immunogenic cell death in triple-negative breast cancer.

Journal: Redox biology

Published: May 16, 2026

Rationally designed tetrasaccharide inhibitors of heparanase with anti-inflammatory activity and protective effects in sepsis.

Rationally designed tetrasaccharide inhibitors of heparanase with anti-inflammatory activity and protective effects in sepsis.

Journal: European journal of medicinal chemistry

Published: April 29, 2026

Updated survival outcomes of SYHX2011 versus albumin-bound paclitaxel in advanced breast cancer: A randomized double-blind phase III trial.

Updated survival outcomes of SYHX2011 versus albumin-bound paclitaxel in advanced breast cancer: A randomized double-blind phase III trial.

Journal: Biomolecules & biomedicine

Published: April 23, 2026

Precision immunotherapy for breast cancer: from biomarkers to clinical practice.

Precision immunotherapy for breast cancer: from biomarkers to clinical practice.

Journal: Cancer biology & medicine

Published: April 13, 2026

A novel flavonoid derivative for treating colorectal cancer by suppressing tumor angiogenesis through VEGFR2 inhibition.

A novel flavonoid derivative for treating colorectal cancer by suppressing tumor angiogenesis through VEGFR2 inhibition.

Journal: Journal of advanced research

Published: February 22, 2026

Spatiotemporal Delivery of Stem Cell-Derived Extracellular Vesicles for Rapid Wound Healing.

Spatiotemporal Delivery of Stem Cell-Derived Extracellular Vesicles for Rapid Wound Healing.

Journal: Angewandte Chemie (International ed. in English)

Published: January 24, 2026

Retraction Note: BRCA1 inhibits AR-mediated proliferation of breast cancer cells through the activation of SIRT1.

Retraction Note: BRCA1 inhibits AR-mediated proliferation of breast cancer cells through the activation of SIRT1.

Journal: Scientific reports

Published: January 13, 2026

A Self-Propelled Molecular Rocket Triggers Ferroptosis and Apoptosis for Improving Herceptin Resistance in Cancer Therapy.

A Self-Propelled Molecular Rocket Triggers Ferroptosis and Apoptosis for Improving Herceptin Resistance in Cancer Therapy.

Journal: Chemistry (Weinheim an der Bergstrasse, Germany)

Published: January 11, 2026

Albumin-Bound Paclitaxel (SYHX2011) in Patients with Advanced Breast Cancer: A Multicenter, Randomized, Double-Blind, Phase III Study.

Albumin-Bound Paclitaxel (SYHX2011) in Patients with Advanced Breast Cancer: A Multicenter, Randomized, Double-Blind, Phase III Study.

Journal: Cancer communications (London, England)

Published: December 09, 2025

Showing 1-12 of 270

Last Updated: 09/26/2026